Search Results 81-90 of 18997 for prostate cancer
"Men with castration-resistant prostate cancer have abysmal survival rates, typically living an average of two years once hormone therapies fail," says Manish ...
Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and ...
... prostate cancers and the surveillance of less aggressive prostate cancers ... Prostate cancer is the most common cancer in men. Over the last several ...
This aim will be accomplished through qualitative focus group study of advanced prostate cancer patients who exhibit both extremes of financial toxicity.
The purpose of this study is to determine if prostate cancer patients treated with proton therapy as compared to IMRT experience improved QOL (validated EPIC ...
PBT is another type of external radiation treatment for prostate cancer that is used in a few centers in the United States. Protons are tiny particles with ...
If the first therapy to treat prostate cancer doesn't work, there are other options available — with one exception. ... According to Lonnie Fynskov, a Mayo Clinic ...
But the study suggests that if a mans PSA level is rising quickly, a prostate biopsy is reasonable to determine if he has prostate cancer. These findings are ...
This is a biomarker preselected, randomized, open-label, multicenter, phase II study in men with metastatic castration resistant prostate cancer (mCRPC).
Find out how doctors use the choline C-11 PET scan to detect recurrent prostate cancer sooner than is possible with standard tests.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.